VestGen Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
VestGen Advisors's UTHR Position: Q3 2026 in Review
VestGen Advisors sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 872 shares — an estimated $472K sold.
VestGen Advisors first reported a position in UTHR in Q1 2026 and held it in 2 quarters. The position peaked at $472K in Q2 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- VestGen Advisors reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
- VestGen Advisors sold 872 United Therapeutics shares in Q3 2026, an estimated $472K.
- VestGen Advisors first reported a position in United Therapeutics in Q1 2026 and held it in 2 quarters.
- VestGen Advisors's United Therapeutics position peaked at $472K in Q2 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.